Papers/PMID:31740020
Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.
The American journal of cardiology2020The record
2 findings drawn from this paper, on 1 compound across 2 endpoints, 2 of them null.
What it reported
How to read these marksEvery finding here is a null result.
What did not
2 findings
all-cis-5,8,11,14,17-icosapentaenoic acid — no detected effect on incidence of stroke
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull result“However, combined therapy of EPA + statin demonstrated no significant association on incidence of stroke when compared with statin alone or all-cause mortality.”
Quoted verbatim from Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.. - Study
- meta-analysis
- Population
- Meta-analysis with trial sequential analysis of 5 RCTs (n=27,415) of EPA + statin vs statin alone; statin given as background therapy in both arms.
Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.2020PMID:31740020
all-cis-5,8,11,14,17-icosapentaenoic acid — no detected effect on all-cause mortality
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull result“However, combined therapy of EPA + statin demonstrated no significant association on incidence of stroke when compared with statin alone or all-cause mortality.”
Quoted verbatim from Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.. - Study
- meta-analysis
- Population
- Meta-analysis with trial sequential analysis of 5 RCTs (n=27,415) of EPA + statin vs statin alone; statin given as background therapy in both arms.
Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.2020PMID:31740020